OA
TDOC icon

Oxbow Advisors’s Teladoc Health TDOC Stock Holding History

Oxbow Advisors’s Portfolio TDOC Stock Details TDOC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-2,379
Closed -$432K – 301
2021
Q1 		$432K Buy
2,379
+1,039
+78% +$241K 0.05% 209
2020
Q4 		$268K Buy
+1,340
New +$272K 0.03% 219

Other funds holding TDOC

AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
GCGM
General Catalyst Group Management Cambridge, Massachusetts $189M AUM 10.96% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Oxbow Advisors's TDOC Position: Q2 2021 in Review

Oxbow Advisors sold out of Teladoc Health (TDOC) in Q2 2021, closing a stake of 2,379 shares — an estimated $432K sold.

Oxbow Advisors first reported a position in TDOC in Q4 2020 and held it in 2 quarters. The position peaked at $432K in Q1 2021. 829 funds tracked by Wall St. Rank hold TDOC as of Q2 2021.

  • Oxbow Advisors reported no remaining Teladoc Health position as of Q2 2021 after selling out during the quarter.
  • Oxbow Advisors sold 2,379 Teladoc Health shares in Q2 2021, an estimated $432K.
  • Oxbow Advisors first reported a position in Teladoc Health in Q4 2020 and held it in 2 quarters.
  • Oxbow Advisors's Teladoc Health position peaked at $432K in Q1 2021.
  • 829 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2021.

Based on Oxbow Advisors's 13F filing for Q2 2021, filed 4 Aug 2021.